4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS 220000-87-3 Sorafenib Tosylate Entèmedyè Faktori Segondè Pite
Pwovizyon Komèsyal Sorafenib Tosylate ak entèmedyè ki gen rapò:
Sorafenib Tosylate CAS: 475207-59-1
Sorafenib CAS: 284461-73-0
4-Chloro-N-Methyl-2-Pyridinecarboxamide CAS: 220000-87-3
4-(4-Aminophenoxy)-N-Methylpicolinamide CAS: 284462-37-9
4-Chloro-3-(Trifluoromethyl)phenyl Isocyanate CAS: 327-78-6
| Non Chimik | 4-Chloro-N-Methyl-2-Pyridinecarboxamide |
| Sinonim | 4-Chloro-N-Methylpicolinamid;N-Methyl-4-Chloropyridine-2-Carboxamide;4-Chloro-N-Methylpyridine-2-Carboxamide |
| Nimewo CAS | 220000-87-3 |
| Nimewo CAT | RF-PI165 |
| Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
| Fòmil molekilè | C7H7ClN2O |
| Pwa molekilè | 170,60 |
| Pwen k ap fonn | 41.0 ~ 438.0 ℃ |
| Pwen bouyi | 317.8 ℃ nan 760 mmHg |
| Dansite | 1.264 g/cm3 |
| Solibilite (Soluble nan) | Methanol, Ethylacetate |
| Kondisyon Shipping | Anbyen |
| Mak | Ruifu Chimik |
| Atik | Espesifikasyon |
| Aparans | Off-blan pou limyè jòn poud |
| Idantifikasyon | (1) MS (2) 1H-NMR |
| Pite / Metòd analiz | 98.0% ~ 101.0% (sou baz cheche) (HPLC) |
| Imidite (KF) | ≤1.0% |
| Pèt sou siye | ≤1.0% |
| Metal lou | ≤20ppm |
| Single enpurte | ≤1.0% |
| Enpurte total | ≤2.0% |
| Tès Creole | Enterprise Standard |
| Itilizasyon | Entèmedyè Sorafenib Tosylate (CAS: 475207-59-1) |
Pake: Boutèy, sak papye aliminyòm, tanbou katon, 25kg / tanbou, oswa selon kondisyon kliyan an.
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè, imidite ak ensèk nuizib.
Shanghai Ruifu Chemical Co, Ltd se manifakti dirijan ak founisè nan 4-Chloro-N-Methyl-2-Pyridinecarboxamide (CAS: 220000-87-3) ak kalite siperyè, li se yon entèmedyè tipikman nan sentèz Sorafenib Tosylate ( CAS: 475207-59-1).Sorafenib Tosylate se yon nouvo kalite dwòg antitumor milti-sib, te devlope pa Alman Bayer Pharmaceuticals yo, epi li montre aktivite antitumoral awogan nan tès preklinik sou bèt.Sorafenib disponib nan tablèt 200 mg pou administrasyon oral epi li itilize nan tretman RCC ak HCC.Sorafenib Tosylate (CAS: 475207-59-1) ka afekte selil timè yo ak veso sangen timè yo.
